ALKS 7119
/ Alkermes
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 12, 2022
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
(PubMed, Br J Clin Pharmacol)
- "In line with ALKS 7119's in vitro pharmacological profile, the clinical profile observed in this study is most comparable to SERT inhibition."
Clinical • Journal • CNS Disorders • Mental Retardation • Psychiatry
1 to 1
Of
1
Go to page
1